N. Bashir

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.

C. Hurt, D. Cunningham, J. Staffurth, 2013, The Lancet. Oncology.

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer

C. Hurt, D. Cunningham, J. Bridgewater, 2015, British Journal of Cancer.

Hughes abdominal closure versus standard mass closure to reduce incisional hernias following surgery for colorectal cancer: the HART RCT.

J. Torkington, B. Sewell, G. Fegan, 2022, Health technology assessment.

Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART)

P. Ziprin, J. Trickett, J. Reilly, 2022, The British journal of surgery.

Hughes Abdominal Repair Trial (HART) – Abdominal wall closure techniques to reduce the incidence of incisional hernias: study protocol for a randomised controlled trial

R. Hargest, J. Torkington, J. Ansell, 2016, Trials.

Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol

J. Gregory, A. Marwaha, T. Tree, 2021, BMJ Open.

Hughes Abdominal Repair Trial (HART)—abdominal wall closure techniques to reduce the incidence of incisional hernias: feasibility trial for a multicentre, pragmatic, randomised controlled trial

I. Russell, J. Torkington, J. Horwood, 2017, BMJ Open.